LP
AMED

LMR Partners’s Amedisys AMED Stock Holding History

LMR Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-283,100
Closed -$27.9M – 1436
2025
Q2 		$27.9M Hold
283,100
– – 0.2% 115
2025
Q1 		$26.2M Sell
283,100
-252,700
-47% -$23.3M 0.25% 102
2024
Q4 		$48.6M Buy
+535,800
New +$49.2M 0.41% 39
2024
Q3 		– Sell
-100
Closed -$9.18K – 1267
2024
Q2 		$9.18K Hold
100
– – ﹤0.01% 1010
2024
Q1 		$9.22K Buy
+100
New +$9.37K ﹤0.01% 1061

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

LMR Partners's AMED Position: Q3 2025 in Review

LMR Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 259,402 shares — an estimated $25.5M sold.

LMR Partners first reported a position in AMED in Q3 2015 and held it in 10 quarters. The position peaked at $36.4M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • LMR Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 259,402 Amedisys shares in Q3 2025, an estimated $25.5M.
  • LMR Partners first reported a position in Amedisys in Q3 2015 and held it in 10 quarters.
  • LMR Partners's Amedisys position peaked at $36.4M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.